Eligibility for Disease Modifying Therapies (DMTs) in Dementia [A.I.]
Oct 20 2024
14 mins
STUDIES:Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, Payne M, Eng O, Huzzey L, Clare A, Green K. Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2024 May 15.Laurell AA, Venkataraman AV, Schmidt T, Montagnese M, Mueller C, Stewart R, Lewis J, Mundell C,